Suchergebnisse - "Ramachandram, Dinesh Sangarran"

PubPharm (107)

21

Risk of Thrombosis With the Use of Tocilizumab in Patients With COVID-19

enthalten in: The Annals of pharmacotherapy | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.

CommentOn: Ann Pharmacother. 2023 Jul;57(7):769-775. - PMID 36314277

22

Embracing Imatinib : a novel approach to safeguarding the endothelial barrier in patients with COVID-19

enthalten in: Angiogenesis | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.

CommentOn: Angiogenesis. 2023 Apr 27;:null. - PMID 37103631

23

Systematic review and meta-analysis of anti-CD20 treatments in patients with COVID-19: an assessment of severe illness and mortality outcomes

enthalten in: Inflammopharmacology | 2023

von Kow, C. | Ramachandram, D. | Hasan, S. | +1

24

Intermediate- to high-dose dexamethasone versus low-dose dexamethasone in patients with COVID-19 requiring respiratory support : a systematic review and meta-analysis of randomized trials

enthalten in: Inflammopharmacology | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.

25

Killing two birds with one stone : The potential of iron supplementation in Chinese HFrEF patients

enthalten in: Journal of the Chinese Medical Association : JCMA | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.

26

RAAS inhibitors in COVID-19 : They are not all the same!

enthalten in: Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.

CommentOn: Rev Port Cardiol. 2023 Apr;42(4):373-383. - PMID 36893838

27

Favipiravir and hyperuricemia in patients with COVID-19-suggestions for future studies

enthalten in: The Lancet regional health. Southeast Asia | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.

28

The impact of preadmission/prediagnosis use of GLP-1 receptor agonists on COVID-19 mortality in patients with diabetes : A systematic review and meta-analysis

enthalten in: Health science reports | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.

29

Famotidine : A potential mitigator of mast cell activation in post-COVID-19 cognitive impairment

enthalten in: Journal of psychosomatic research | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.

CommentOn: J Psychosom Res. 2023 Sep;172:111389. - PMID 37327698

30

Anakinra for the prophylaxis of venous thromboembolism in patients with COVID-19

enthalten in: Inflammopharmacology | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.